Two polyacetylenic antibiotics, peniophorin A and B, have been isolated from a strain of Peniophora affinis. Both have antibacterial and antifungal activity, but B is 3 to 20 times more active than A. Gram-positive cocci and a strain of Proteus vulgaris were especially susceptible to these two antibiotics. Both peniophorins contained an aromatic ring; B was an acid, and A was neutral. Peniophorin B was shown to be 2-(1-oxo-2,4-pentadiynl)phenyl acetic acid. The structure of A was only partially elucidated; it is suspected to be 6-[2-(1-oxo-2,4-pentadiynl)phenyl]5-methoxy-3-oxo-4-hexene-1-ol.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC283844 | PMC |
| http://dx.doi.org/10.1128/AAC.17.4.636 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Elucidation of Antimicrobials and Biofilm Inhibitors Derived from a Polyacetylene Core.
Molecules
December 2024
Department of Chemistry, William & Mary, Williamsburg, VA 23185, USA.
The development of new antibiotics with unique mechanisms of action is paramount to combating the growing threat of antibiotic resistance. Recently, based on inspiration from natural products, an asymmetrical polyacetylene core structure was examined for its bioactivity and found to have differential specificity for different bacterial species based on the substituents around the conjugated alkyne. This research further probes the structural requirements for bioactivity through a systematic synthesis and investigation of new compounds with variable carbon chain length, alkynyl subunits, and alcohol substitution.
View Article and Find Full Text PDFBioassay-guided isolation of antibacterial and anti-inflammatory components from Atractylodes lancea.
Phytochemistry
November 2024
Department of Pharmacy, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University, Wuhan, 430071, China. Electronic address:
Article Synopsis
- * It was the first time these compounds were tested for antibacterial activity against MRSA and also evaluated for anti-inflammatory effects.
- * Notably, compound 21 showed strong antibacterial activity against multiple bacteria and potential as a broad-spectrum antibacterial agent, while most compounds demonstrated significant anti-inflammatory effects possibly targeting iNOS.
Genome mining for new enediyne antibiotics.
Curr Opin Chem Biol
August 2024
Department of Chemistry, Princeton University, Princeton, NJ 08544, USA; Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA. Electronic address:
Enediyne antibiotics epitomize nature's chemical creativity. They contain intricate molecular architectures that are coupled with potent biological activities involving double-stranded DNA scission. The recent explosion in microbial genome sequences has revealed a large reservoir of novel enediynes.
View Article and Find Full Text PDFArticle Synopsis
- Dynemicin A has been primarily studied since 1989 as an anthraquinone-fused enediyne (AFE), but new research focuses on the DNA interaction of other AFEs like tiancimycins and yangpumicins.
- The study finds that these AFEs show strong cytotoxic effects on tumor cells, with tiancimycin A particularly effective in reducing breast tumor growth while causing minimal toxicity.
- Molecular simulations suggest that tiancimycin A binds to DNA differently than dynemicin A, allowing it to precisely target certain DNA sequences, which could inform the design of new AFEs for cancer treatment.
pHLIP targeted intracellular delivery of calicheamicin.
Int J Pharm
April 2024
Physics Department, University of Rhode Island, Kingston, RI, USA. Electronic address:
Calicheamicin is a potent, cell-cycle independent enediyne antibiotic that binds and cleaves DNA. Toxicity has led to its use in a targeted form, as an antibody-drug conjugate approved for the treatment of liquid tumors. We used a reduced calicheamicin to conjugate it to a single cysteine residue at the membrane-inserting end of a pH Low Insertion Peptide (pHLIP) that targets imaging and therapeutic agents to tumors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!